国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Spirogyra maxima 30S ribosomal protein S3, chloroplastic (rps3) CSB-YP531001FKM
CSB-EP531001FKM
CSB-BP531001FKM
CSB-MP531001FKM
CSB-EP531001FKM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Spirogyra maxima Translation initiation factor IF-1, chloroplastic (infA) CSB-YP531002FKM
CSB-EP531002FKM
CSB-BP531002FKM
CSB-MP531002FKM
CSB-EP531002FKM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brasenia schreberi Maturase K (matK) CSB-YP531003BWA
CSB-EP531003BWA
CSB-BP531003BWA
CSB-MP531003BWA
CSB-EP531003BWA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nymphaea odorata Maturase K (matK), partial CSB-YP531004NIE
CSB-EP531004NIE
CSB-BP531004NIE
CSB-MP531004NIE
CSB-EP531004NIE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pandorea jasminoides Ribulose bisphosphate carboxylase large chain (rbcL) CSB-YP531005EQX
CSB-EP531005EQX
CSB-BP531005EQX
CSB-MP531005EQX
CSB-EP531005EQX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hordeum vulgare NAD (P)H-quinone oxidoreductase subunit H, chloroplastic CSB-YP531006HWQ
CSB-EP531006HWQ
CSB-BP531006HWQ
CSB-MP531006HWQ
CSB-EP531006HWQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hydrangea quercifolia Maturase K (matK) CSB-YP531007HXP
CSB-EP531007HXP
CSB-BP531007HXP
CSB-MP531007HXP
CSB-EP531007HXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halesia carolina Ribulose bisphosphate carboxylase large chain (rbcL) CSB-YP531008HTG
CSB-EP531008HTG
CSB-BP531008HTG
CSB-MP531008HTG
CSB-EP531008HTG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vigna radiata var. radiata Ribulose bisphosphate carboxylase/oxygenase activase, chloroplastic (RCA) CSB-YP531009VFL
CSB-EP531009VFL
CSB-BP531009VFL
CSB-MP531009VFL
CSB-EP531009VFL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant ATP synthase subunit alpha, plastid (atpA), partial CSB-YP531010EZF
CSB-EP531010EZF
CSB-BP531010EZF
CSB-MP531010EZF
CSB-EP531010EZF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis serovar L2 tRNA-specific 2-thiouridylase mnmA (mnmA) CSB-YP531011DSG
CSB-EP531011DSG
CSB-BP531011DSG
CSB-MP531011DSG
CSB-EP531011DSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis serovar L2 DNA-directed RNA polymerase subunit beta (rpoB), partial CSB-YP531012DSG
CSB-EP531012DSG
CSB-BP531012DSG
CSB-MP531012DSG
CSB-EP531012DSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis serovar L2 Chaperone protein DnaJ (dnaJ) CSB-YP531013DSG
CSB-EP531013DSG
CSB-BP531013DSG
CSB-MP531013DSG
CSB-EP531013DSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis serovar L2 3-phosphoshikimate 1-carboxyvinyltransferase (aroA) CSB-YP531014DSG
CSB-EP531014DSG
CSB-BP531014DSG
CSB-MP531014DSG
CSB-EP531014DSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis serovar L2 UPF0235 protein CTL0644 (CTL0644) CSB-YP531015DSG
CSB-EP531015DSG
CSB-BP531015DSG
CSB-MP531015DSG
CSB-EP531015DSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis serovar L2 Cytidylate kinase (cmk) CSB-YP531016DSG
CSB-EP531016DSG
CSB-BP531016DSG
CSB-MP531016DSG
CSB-EP531016DSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis serovar L2 Holliday junction ATP-dependent DNA helicase RuvA (ruvA) CSB-YP531017DSG
CSB-EP531017DSG
CSB-BP531017DSG
CSB-MP531017DSG
CSB-EP531017DSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis serovar L2 30S ribosomal protein S11 (rpsK) CSB-YP531018DSG
CSB-EP531018DSG
CSB-BP531018DSG
CSB-MP531018DSG
CSB-EP531018DSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis serovar L2 50S ribosomal protein L18 (rplR) CSB-YP531019DSG
CSB-EP531019DSG
CSB-BP531019DSG
CSB-MP531019DSG
CSB-EP531019DSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis serovar L2 50S ribosomal protein L3 (rplC) CSB-YP531020DSG
CSB-EP531020DSG
CSB-BP531020DSG
CSB-MP531020DSG
CSB-EP531020DSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>